Alnylam
Biotechnology is on a mission to cure patients, protect our climate, nourish humanity, and make seemingly impossible breakthroughs possible. But breakthroughs don’t happen all by themselves. That’s where BIO comes in.
Receive the best resource for the biotech industry with Good Day BIO, the only daily newsletter at the intersection of biotech, politics, and policy.
Watch I Am BIO Videos
The COVID-19 pandemic has shown the world the importance of science and biotech breakthroughs— biotechnology innovation is leading the charge to get the world back on track. Meet the people behind these breakthroughs, from scientists in the labs, to inspiring patients and patient advocates, to the young people who are the next generation of biotech leaders.
For more than a year now, COVID has been society’s focus—and rightly so. But today we turn our attention to another virus—HIV. After 40 years, there is still no cure or a vaccine for the disease. In this episode, we hear from Dr. Anthony Fauci and CEO of innovative company American Gene Technologies, Jeff Galvin, about the past, present, and future of HIV treatments and medications. Is there a cure on the horizon?
They are not the household names, but the medications they are researching and developing could be the lifeline patients are waiting for. Today we explore how drug price controls—now making their way through Congress—could have unintended consequences for the small biotechs that are the engine of the drug development ecosystem. And even worse, for the patients who need them most.
